News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sequenta, Inc. Develops Novel Method for Identifying Antigen-Specific T Cells by Combining Conventional Immune Monitoring Assays With High-Throughput Repertoire Sequencing



9/20/2013 11:01:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sequenta, Inc., today published results demonstrating that a combination of traditional immune assays and next-generation sequencing can be used to characterize immune responses at a level not possible using standard assays alone. Conventional immune monitoring assays, which enable identification of populations of T cells that either bind to or respond to antigen via T cell receptors, are able to provide information on only the totality of an immune response. These assays alone cannot be used to characterize the component T cells (called “clonotypes”) that together contribute to an immune response.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES